{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:10:01Z","timestamp":1790809801066,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002343","name":"Institut de Recherche Robert-Sauv\u00e9 en Sant\u00e9 et en S\u00e9curit\u00e9 du Travail","doi-asserted-by":"publisher","award":["2014-0001"],"award-info":[{"award-number":["2014-0001"]}],"id":[{"id":"10.13039\/501100002343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Arch Occup Environ Health"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00420-021-01731-w","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T10:08:21Z","timestamp":1629367701000},"page":"1877-1888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?"],"prefix":"10.1007","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-0433","authenticated-orcid":false,"given":"France","family":"Labr\u00e8che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Roberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Yennek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bussi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"1731_CR1","unstructured":"American Society of Health System Pharmacists (2018) ASHP Guidelines on Handling Hazardous Drugs. In: Drug Distribution and Control. American Society of Health-System Pharmacists, Bethesda, MD, USA. https:\/\/www.ashp.org\/-\/media\/assets\/policy-guidelines\/docs\/guidelines\/handling-hazardous-drugs.ashx"},{"key":"1731_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/15459624.2015.1029610","volume":"12","author":"JM Boiano","year":"2015","unstructured":"Boiano JM, Steege AL, Sweeney MH (2015) Adherence to precautionary guidelines for compounding antineoplastic drugs: a survey of nurses and pharmacy practitioners. J Occup Environ Hyg 12:588\u2013602. https:\/\/doi.org\/10.1080\/15459624.2015.1029610","journal-title":"J Occup Environ Hyg"},{"key":"1731_CR3","doi-asserted-by":"publisher","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68:394\u2013424 doi:https:\/\/doi.org\/10.3322\/caac.21492","DOI":"10.3322\/caac.21492"},{"key":"1731_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0003-4878(00)00036-3","volume":"44","author":"DH Brouwer","year":"2000","unstructured":"Brouwer DH, Boeniger MF, van Hemmen J (2000) Hand wash and manual skin wipes. Ann Occup Hyg 44:501\u2013510. PMID: 11042251","journal-title":"Ann Occup Hyg"},{"key":"1731_CR5","doi-asserted-by":"publisher","unstructured":"Chauchat L, Tanguay C, Caron NJ, Gagne S, Labreche F, Bussieres JF (2018) Surface contamination with ten antineoplastic drugs in 83 Canadian centers. J Oncol Pharm Pract:1078155218773862 https:\/\/doi.org\/10.1177\/1078155218773862","DOI":"10.1177\/1078155218773862"},{"key":"1731_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","volume":"78","author":"J Ciccolini","year":"2016","unstructured":"Ciccolini J, Serdjebi C, Peters GJ, Giovannetti E (2016) Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective. Cancer Chemother Pharmacol 78:1\u201312. https:\/\/doi.org\/10.1007\/s00280-016-3003-0","journal-title":"Cancer Chemother Pharmacol"},{"key":"1731_CR7","doi-asserted-by":"publisher","unstructured":"Colombo M, Jeronimo M, Astrakianakis G, Apte C, Hon CY (2017) Wipe sampling method and evaluation of environmental variables for assessing surface contamination of 10 antineoplastic drugs by liquid chromatography\/tandem mass spectrometry annals of work exposures and health 61:1003\u20131014 https:\/\/doi.org\/10.1093\/annweh\/wxx070","DOI":"10.1093\/annweh\/wxx070"},{"key":"1731_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1196\/annals.1371.021","volume":"1076","author":"TH Connor","year":"2006","unstructured":"Connor TH (2006) Hazardous anticancer drugs in health care: environmental exposure assessment. Ann N Y Acad Sci 1076:615\u2013623. https:\/\/doi.org\/10.1196\/annals.1371.021","journal-title":"Ann N Y Acad Sci"},{"key":"1731_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/JOM.0b013e3181f72b63","volume":"52","author":"TH Connor","year":"2010","unstructured":"Connor TH et al (2010) Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med 52:1019\u20131027. https:\/\/doi.org\/10.1097\/JOM.0b013e3181f72b63","journal-title":"J Occup Environ Med"},{"key":"1731_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1515\/pthp-2016-0009","volume":"1","author":"TH Connor","year":"2016","unstructured":"Connor TH, Smith JP (2016) New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings. Pharmaceutical Technol Hospital Pharmacy 1:107\u2013114. https:\/\/doi.org\/10.1515\/pthp-2016-0009","journal-title":"Pharmaceutical Technol Hospital Pharmacy"},{"key":"1731_CR11","doi-asserted-by":"publisher","unstructured":"Connor TH, Zock MD, Snow AH (2016) Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: methodology and recommendations. J Occup Environ Hyg 13:658\u2013667 https:\/\/doi.org\/10.1080\/15459624.2016.1165912","DOI":"10.1080\/15459624.2016.1165912"},{"key":"1731_CR12","doi-asserted-by":"publisher","unstructured":"Crul M, Hilhorst S, Breukels O, Bouman-d\u2019Onofrio JRC, Stubbs P, van Rooij JG (2020) Occupational exposure of pharmacy technicians and cleaning staff to cytotoxic drugs in Dutch hospitals Journal of Occupational and Environmental Hygiene 17:343-352 doi:https:\/\/doi.org\/10.1080\/15459624.2020.1776299","DOI":"10.1080\/15459624.2020.1776299"},{"key":"1731_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00420-004-0595-1","volume":"78","author":"W Fransman","year":"2005","unstructured":"Fransman W, Vermeulen R, Kromhout H (2005) Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occupational Environ Health 78:403\u2013412. https:\/\/doi.org\/10.1007\/s00420-004-0595-1","journal-title":"Int Arch Occupational Environ Health"},{"key":"1731_CR14","doi-asserted-by":"publisher","unstructured":"Graeve CU, McGovern PM, Alexander B, Church T, Ryan A, Polovich M (2017) Occupational Exposure to Antineoplastic Agents:An Analysis of Health Care Workers and Their Environments Workplace Health & Safety 65:9-20 doi:https:\/\/doi.org\/10.1177\/2165079916662660","DOI":"10.1177\/2165079916662660"},{"key":"1731_CR15","doi-asserted-by":"publisher","unstructured":"Gurusamy KS, Best LM, Tanguay C, Lennan E, Korva M, Bussieres JF (2018) Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff The Cochrane database of systematic reviews 3:Cd012860 doi:https:\/\/doi.org\/10.1002\/14651858.CD012860.pub2","DOI":"10.1002\/14651858.CD012860.pub2"},{"key":"1731_CR16","unstructured":"Health and Safety Executive (s.d.) Safe handling of cytotoxic drugs in the workplace. HSE. http:\/\/www.hse.gov.uk\/healthservices\/safe-use-cytotoxic-drugs.htm. Accessed 2018 Dec 07"},{"key":"1731_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00420-007-0211-2","volume":"81","author":"M Hedmer","year":"2008","unstructured":"Hedmer M, Hoglund P, Cavallin-Stahl E, Albin M, Jonsson BA (2008a) Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients. Int Arch Occup Environ Health 81:285\u2013293. https:\/\/doi.org\/10.1007\/s00420-007-0211-2","journal-title":"Int Arch Occup Environ Health"},{"key":"1731_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00420-007-0284-y","volume":"81","author":"M Hedmer","year":"2008","unstructured":"Hedmer M, Tinnerberg H, Axmon A, Jonsson BA (2008b) Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int Arch Occup Environ Health 81:899\u2013911. https:\/\/doi.org\/10.1007\/s00420-007-0284-y","journal-title":"Int Arch Occup Environ Health"},{"key":"1731_CR19","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1039\/c2em10704j","volume":"14","author":"M Hedmer","year":"2012","unstructured":"Hedmer M, Wohlfart G (2012) Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals. J Environ Monit 14:1968\u20131975. https:\/\/doi.org\/10.1039\/c2em10704j","journal-title":"J Environ Monit"},{"key":"1731_CR20","unstructured":"Heggie GD, Sommadossi JP, Cross DS, Huster WJ, Diasio RB (1987) Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile Cancer Res 47:2203\u20132206. PMID: 3829006"},{"key":"1731_CR21","doi-asserted-by":"crossref","unstructured":"Hilliquin D, Tanguay C, Gagn\u00e9 S, Caron NJ, Bussi\u00e8res J-F (2019) Cross-Sectional Evaluation of Surface Contamination with Antineoplastic Drugs in Canadian Health Care Centres Can J Hosp Pharm 72:377\u2013384.  PMID: 31692608","DOI":"10.4212\/cjhp.v72i5.2931"},{"key":"1731_CR22","doi-asserted-by":"publisher","unstructured":"Hirst M, Tse S, Mills DG, Levin L, White DF (1984) Occupational exposure to cyclophosphamide Lancet (London, England) 1:186\u2013188 https:\/\/doi.org\/10.1016\/s0140-6736(84)92111-1","DOI":"10.1016\/s0140-6736(84)92111-1"},{"key":"1731_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4212\/cjhp.v64i5.1067","volume":"64","author":"CY Hon","year":"2011","unstructured":"Hon CY, Astrakianakis G, Danyluk Q, Chu W (2011) Pilot evaluation of dermal contamination by antineoplastic drugs among hospital pharmacy personnel. Can J Hospital Pharmacy 64:327\u2013332. https:\/\/doi.org\/10.4212\/cjhp.v64i5.1067","journal-title":"Can J Hospital Pharmacy"},{"key":"1731_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/1078155213497070","volume":"20","author":"CY Hon","year":"2014","unstructured":"Hon CY, Chua PP, Danyluk Q, Astrakianakis G (2014a) Examining factors that influence the effectiveness of cleaning antineoplastic drugs from drug preparation surfaces: a pilot study. J Oncol Pharm Pract 20:210\u2013216. https:\/\/doi.org\/10.1177\/1078155213497070","journal-title":"J Oncol Pharm Pract"},{"key":"1731_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/15459624.2013.789743","volume":"10","author":"CY Hon","year":"2013","unstructured":"Hon CY, Teschke K, Chu W, Demers P, Venners S (2013) Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. J Occup Environ Hyg 10:374\u2013383. https:\/\/doi.org\/10.1080\/15459624.2013.789743","journal-title":"J Occup Environ Hyg"},{"key":"1731_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/annhyg\/meu019","volume":"58","author":"CY Hon","year":"2014","unstructured":"Hon CY, Teschke K, Demers PA, Venners S (2014b) Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system. Ann Occup Hyg 58:761\u2013770. https:\/\/doi.org\/10.1093\/annhyg\/meu019","journal-title":"Ann Occup Hyg"},{"key":"1731_CR27","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012) Pharmaceuticals. Volume 100 A. A review of human carcinogens IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 100:1-401. https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono100A.pdf"},{"key":"1731_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4212\/cjhp.v68i4.1467","volume":"68","author":"A Janes","year":"2015","unstructured":"Janes A, Tanguay C, Caron NJ, Bussieres JF (2015) Environmental contamination with cyclophosphamide, ifosfamide, and methotrexate: a study of 51. Can Centres Can J Hospital Pharm 68:279\u2013289. https:\/\/doi.org\/10.4212\/cjhp.v68i4.1467","journal-title":"Can Centres Can J Hospital Pharmacy"},{"key":"1731_CR29","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1007\/s00216-015-8868-y","volume":"407","author":"M Jeronimo","year":"2015","unstructured":"Jeronimo M, Colombo M, Astrakianakis G, Hon CY (2015) A surface wipe sampling and LC-MS\/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers. Anal Bioanal Chem 407:7083\u20137092. https:\/\/doi.org\/10.1007\/s00216-015-8868-y","journal-title":"Anal Bioanal Chem"},{"key":"1731_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/ecc.12249","volume":"24","author":"C Kieffer","year":"2015","unstructured":"Kieffer C et al (2015) Preventing the contamination of hospital personnel by cytotoxic agents: evaluation and training of the para-professional healthcare workers in oncology units. Eur J Cancer Care (engl) 24:404\u2013410. https:\/\/doi.org\/10.1111\/ecc.12249","journal-title":"Eur J Cancer Care (engl)"},{"key":"1731_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/annhyg\/mes081","volume":"57","author":"TK Kiffmeyer","year":"2013","unstructured":"Kiffmeyer TK, Tuerk J, Hahn M, Stuetzer H, Hadtstein C, Heinemann A, Eickmann U (2013) Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies\u2014the MEWIP project. Ann Occup Hyg 57:444\u2013455. https:\/\/doi.org\/10.1093\/annhyg\/mes081","journal-title":"Ann Occup Hyg"},{"key":"1731_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00420-012-0742-z","volume":"86","author":"B Kopp","year":"2013","unstructured":"Kopp B, Schierl R, Nowak D (2013) Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings. Int Arch Occup Environ Health 86:47\u201355. https:\/\/doi.org\/10.1007\/s00420-012-0742-z","journal-title":"Int Arch Occup Environ Health"},{"key":"1731_CR33","doi-asserted-by":"publisher","unstructured":"Lavou\u00e9 J et al. (2018) Expostats: a bayesian toolkit to aid the interpretation of occupational exposure measurements. Ann Work Exposures Health https:\/\/doi.org\/10.1093\/annweh\/wxy100","DOI":"10.1093\/annweh\/wxy100"},{"key":"1731_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/annhyg\/mei023","volume":"49","author":"HJ Mason","year":"2005","unstructured":"Mason HJ, Blair S, Sams C, Jones K, Garfitt SJ, Cuschieri MJ, Baxter PJ (2005) Exposure to antineoplastic drugs in two UK hospital pharmacy units. Ann Occup Hyg 49:603\u2013610. https:\/\/doi.org\/10.1093\/annhyg\/mei023","journal-title":"Ann Occup Hyg"},{"key":"1731_CR35","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.2146\/ajhp180631","volume":"75","author":"MA McDiarmid","year":"2018","unstructured":"McDiarmid MA, Polovich M, Power LA, Connor TH, Kienle PC (2018) Published review of closed-system drug-transfer devices: limitations and implications. Am J Health Syst Pharm 75:1982\u20131985. https:\/\/doi.org\/10.2146\/ajhp180631","journal-title":"Am J Health Syst Pharm"},{"key":"1731_CR36","first-page":"81","volume":"154","author":"S Ndaw","year":"2018","unstructured":"Ndaw S, Denis F, Marsan P, R\u00e9my A, Robert A (2018a) Exposition professionnelle des personnels de sant\u00e9 hospitaliers aux m\u00e9dicaments cytotoxiques. Biom\u00e9trologie et mesure de la contamination des surfaces. R\u00e9f\u00e9rences En Sant\u00e9 Au Travail 154:81\u201392","journal-title":"R\u00e9f\u00e9rences En Sant\u00e9 Au Travail"},{"key":"1731_CR37","unstructured":"Ndaw S, Robert R, Ricolfi C, Denis F, Marsan P (2018b) Soignants et m\u00e9dicaments cytotoxiques. Place de la biom\u00e9trologie dans la ma\u00eetrise des risques dans le temps Bulletin \u00e9pid\u00e9miologique hebdomadaire 12-13:252-127"},{"key":"1731_CR38","doi-asserted-by":"publisher","unstructured":"Ng MG, de Poot S, Schmid K, Cowie H, Semple S, van Tongeren M (2014) A preliminary comparison of three dermal exposure sampling methods: rinses, wipes and cotton gloves. Environ Sci Processes Impacts 16:141\u2013147 https:\/\/doi.org\/10.1039\/c3em00511a","DOI":"10.1039\/c3em00511a"},{"key":"1731_CR39","unstructured":"NIOSH (2004) NIOSH ALERT\u2014Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. DHHS (NIOSH), Cincinnati (Ohio)"},{"key":"1731_CR40","unstructured":"NIOSH (2016) NIOSH list of antineoplastic and other hazardous drugs in health care settings 2016. . U.S. Dept. of Health and Human Services; Centers for Disease Control and Prevention; National Institute for Occupational Safety and Health, Cincinnati, OH"},{"key":"1731_CR41","doi-asserted-by":"publisher","unstructured":"Palamini M, Gagn\u00e9 S, Caron N, Bussi\u00e8res JF (2020) Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results. J Oncol Pharm Pract:1078155220907125 doi:https:\/\/doi.org\/10.1177\/1078155220907125","DOI":"10.1177\/1078155220907125"},{"key":"1731_CR42","unstructured":"Richardson GM, Stantec Consulting Ltd. (2013) 2013 Canadian exposure factors handbook. Toxicology Centre, University of Saskatchewan, p. 33. Saskatoon, SK, Canada"},{"key":"1731_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/15459624.2017.1316389","volume":"14","author":"C Roland","year":"2017","unstructured":"Roland C, Caron N, Bussieres JF (2017) Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: a 2016 follow-up study. J Occup Environ Hyg 14:661\u2013669. https:\/\/doi.org\/10.1080\/15459624.2017.1316389","journal-title":"J Occup Environ Hyg"},{"key":"1731_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/annhyg\/mep050","volume":"53","author":"R Schierl","year":"2009","unstructured":"Schierl R, Bohlandt A, Nowak D (2009) Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann Occup Hyg 53:703\u2013711. https:\/\/doi.org\/10.1093\/annhyg\/mep050","journal-title":"Ann Occup Hyg"},{"key":"1731_CR45","unstructured":"Sessink PJ (2011) Environmental contamination with cytostatic drugs: past, present and future Saf Consid Oncol Pharm Special Edition"},{"key":"1731_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00039896.1994.9940377","volume":"49","author":"PJ Sessink","year":"1994","unstructured":"Sessink PJ, Van de Kerkhof MC, Anzion RB, Noordhoek J, Bos RP (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health 49:165\u2013169. https:\/\/doi.org\/10.1080\/00039896.1994.9940377","journal-title":"Arch Environ Health"},{"key":"1731_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/00039899709602893","volume":"52","author":"PJ Sessink","year":"1997","unstructured":"Sessink PJ, Wittenhorst BC, Anzion RB, Bos RP (1997) Exposure of pharmacy technicians to antineoplastic agents: reevaluation after additional protective measures. Arch Environ Health 52:240\u2013244. https:\/\/doi.org\/10.1080\/00039899709602893","journal-title":"Arch Environ Health"},{"key":"1731_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.toxlet.2011.03.028","volume":"213","author":"C Sottani","year":"2012","unstructured":"Sottani C, Porro B, Imbriani M, Minoia C (2012) Occupational exposure to antineoplastic drugs in four Italian health care settings. Toxicol Lett 213:107\u2013115. https:\/\/doi.org\/10.1016\/j.toxlet.2011.03.028","journal-title":"Toxicol Lett"},{"key":"1731_CR49","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1001\/jamainternmed.2015.4535","volume":"175","author":"ME Tomas","year":"2015","unstructured":"Tomas ME et al (2015) Contamination of health care personnel during removal of personal protective equipment. JAMA Int Med 175:1904\u20131910. https:\/\/doi.org\/10.1001\/jamainternmed.2015.4535","journal-title":"JAMA Int Med"},{"key":"1731_CR50","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1158\/1055-9965.epi-06-0414","volume":"15","author":"LB Travis","year":"2006","unstructured":"Travis LB (2006) The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 15:2020\u20132026. https:\/\/doi.org\/10.1158\/1055-9965.epi-06-0414","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1731_CR51","unstructured":"Working Committee on the Safe Handling of Hazardous Drugs (2008) Prevention Guide\u2014Safe Handling of Hazardous Drugs. Association paritaire pour la sant\u00e9 et la s\u00e9curit\u00e9 du travail du secteur affaires sociales (ASSTSAS), Montreal, QC, Canada"},{"key":"1731_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1078155210380485","volume":"17","author":"J Yoshida","year":"2011","unstructured":"Yoshida J, Koda S, Nishida S, Yoshida T, Miyajima K, Kumagai S (2011) Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan. J Oncol Pharm Pract 17:29\u201338. https:\/\/doi.org\/10.1177\/1078155210380485","journal-title":"J Oncol Pharm Pract"}],"container-title":["International Archives of Occupational and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-021-01731-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00420-021-01731-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-021-01731-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T04:41:05Z","timestamp":1633408865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00420-021-01731-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1007\/s00420-021-01731-w","relation":{},"ISSN":["0340-0131","1432-1246"],"issn-type":[{"value":"0340-0131","type":"print"},{"value":"1432-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,19]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article. None declared by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Ethics Committee of the two participating hospitals and Ethics committee for research on Humans from Universit\u00e9 de Montreal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}